Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | CTSC | P53634 | 3/20 | 0.44 |
| ▸ | PHGDH | O43175 | 3/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.44 |
| ▸ | ESYT2 | A0FGR8 | 2/20 | 0.44 |
| ▸ | NBAS | A2RRP1 | 2/20 | 0.44 |
| ▸ | CNOT1 | A5YKK6 | 2/20 | 0.44 |
| ▸ | TBKBP1 | A7MCY6 | 2/20 | 0.44 |
| ▸ | AGPS | O00116 | 2/20 | 0.44 |
| ▸ | MYO1F | O00160 | 2/20 | 0.44 |
| ▸ | SNAP23 | O00161 | 2/20 | 0.44 |
| ▸ | AP3B1 | O00203 | 2/20 | 0.44 |
| ▸ | PSMD12 | O00232 | 2/20 | 0.44 |
| ▸ | BMPR1B | O00238 | 2/20 | 0.44 |
| ▸ | PGRMC1 | O00264 | 2/20 | 0.44 |
| ▸ | CLIC1 | O00299 | 2/20 | 0.44 |
| ▸ | CDC7 | O00311 | 2/20 | 0.44 |
| ▸ | IPO5 | O00410 | 2/20 | 0.44 |
| ▸ | PLK4 | O00444 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22025047 | 0.92 | KDR (0.49) | KIF11LMNACTSCPHGDHMAPK14 | |
| SCHEMBL22025049 | 0.92 | ABCG2 (0.48) | LMNACTSCPHGDHEGFRMAPK1 | |
| SCHEMBL22024648 | 0.88 | EPHB4 (0.52) | LMNACTSCPHGDHMAPK14ESYT2 | |
| SCHEMBL22024855 | 0.84 | KDR (0.53) | LMNAABL1EGFRPRKCBINSR | |
| SCHEMBL22025053 | 0.83 | KDR (0.50) | MAPK14AURKAABL1EGFRPRKCB | |
| SCHEMBL22025050 | 0.80 | KDM4E (0.46) | LMNAABL1EGFRBCREPHB4 | |
| SCHEMBL22024647 | 0.80 | EPHB4 (0.61) | ABL1EGFRPRKCBINSRLCK | |
| SCHEMBL22065373 | 0.80 | PDE5A (0.46) | LMNALATS1MAPK1HSD17B10ALDH1A1 | |
| SCHEMBL22066416 | 0.79 | PDE5A (0.49) | LMNALATS1ABL1EGFRBCR | |
| SCHEMBL22025337 | 0.79 | DDR1 (0.72) | LMNACTSCPHGDHMAPK14ESYT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352354-B2 | Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof | XIAMEN UNIVERSITY (CN) | 2022-06-07 | — | — | US | disclosed |
| US-20200165246-A1 | SUBSTITUTED PENTA-FUSED HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF | XIAMEN UNIVERSITY (CN) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352354-B2 | Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof | PIKFYVE, PIK3CA, PIK3C2A | KIF11 157/4885LMNA 3498/4885CTSC 1008/4885 |
| US-20200165246-A1 | SUBSTITUTED PENTA-FUSED HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF | PIKFYVE, PIK3CA, PIK3C2A | KIF11 157/4885LMNA 3498/4885CTSC 1008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.